A 3-bp deletion mutation of PTPN11 in an infant with severe Noonan syndrome including hydrops fetalis and juvenile myelomonocytic leukemia

被引:26
|
作者
Yoshida, R
Miyata, M
Nagai, T
Yamazaki, T
Ogata, T
机构
[1] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo 1548567, Japan
[2] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan
[3] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi 47011, Japan
[4] Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Pediat, Koshigaya, Japan
关键词
Noonan syndrome; hydrops fetalis; juvenile myelomonocytic leukemia; PTPN11; intragenic deletion;
D O I
10.1002/ajmg.a.30029
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A de novo 3-bp deletion (179-181delGTG) was identified at exon 3 of the PTPN11 gene in a female infant with severe Noonan phenotype including hydrops fetalis and juvenile myelomonocytic leukemia. Since the 3-bp deletion is predicted to result in loss of the 60th glycine in the N-SH2 domain that is directly involved in the intramolecular interaction between the N-SH2 and the PTP domains of the PTPN11 protein, this mutation would disrupt the N-SH2/PTP binding in the absence of a phosphopeptide, leading to an excessive phosphatase activity. The results expand the spectrum of PTPN11 mutations in Noonan syndrome (NS), and suggest that a PTPN11 mutation leads to a wide range of clinical features of Noonan syndrome. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 37 条
  • [31] Serial investigation of PTPN11 mutation in nonhematopoietic tissues in a patient with juvenile myelomonocytic leukemia who was treated with unrelated cord blood transplantation
    Rika Hiramoto
    Toshihiko Imamura
    Hideki Muramatsu
    Xinan Wang
    Takuyo Kanayama
    Masashi Zuiki
    Hideki Yoshida
    Masaharu Moroto
    Atsushi Fujiki
    Tomohiro Chiyonobu
    Shinya Osone
    Hiroyuki Ishida
    Seiji Kojima
    Hajime Hosoi
    International Journal of Hematology, 2015, 102 : 719 - 722
  • [32] PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center
    Miao, Yan
    Li, Benshang
    Ding, Lixia
    Zhu, Hua
    Luo, Changying
    Wang, Jianmin
    Luo, Chengjuan
    Chen, Jing
    EUROPEAN JOURNAL OF PEDIATRICS, 2020, 179 (03) : 463 - 472
  • [33] PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center
    Yan Miao
    Benshang Li
    Lixia Ding
    Hua Zhu
    Changying Luo
    Jianmin Wang
    Chengjuan Luo
    Jing Chen
    European Journal of Pediatrics, 2020, 179 : 463 - 472
  • [34] Myelodysplastic syndrome with multilineage dysplasia evolving to acute myeloid leukemia: Noonan syndrome with c.218C>T mutation in PTPN11 gene
    Shenoy, Rathika Damodara
    Yeshvanth, Sunil Kumar
    Prasada, Harsha L.
    Shenoy, Vijaya
    Shetty, Vikram
    PEDIATRIC BLOOD & CANCER, 2019, 66 (02)
  • [35] Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome
    Karow, A.
    Steinemann, D.
    Goehring, G.
    Hasle, H.
    Greiner, J.
    Harila-Saari, A.
    Flotho, C.
    Zenker, M.
    Schlegelberger, B.
    Niemeyer, C. M.
    Kratz, C. P.
    LEUKEMIA, 2007, 21 (06) : 1303 - 1305
  • [36] Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome
    A Karow
    D Steinemann
    G Göhring
    H Hasle
    J Greiner
    A Harila-Saari
    C Flotho
    M Zenker
    B Schlegelberger
    C M Niemeyer
    C P Kratz
    Leukemia, 2007, 21 : 1303 - 1305
  • [37] Aurora Kinase B/C Inhibitor GSK1070916 Specifically Targets Juvenile Myelomonocytic Leukemia Cells with SHP2(PTPN11) Mutation
    He, Chunxiao
    Zhang, Dengyang
    Guo, Yao
    Zhao, Yuming
    Huang, Junbin
    Xue, Hongman
    Chen, Chun
    Chen, Yun
    Zhao, Zhizhuang Joe
    BLOOD, 2022, 140 : 3092 - 3092